NORTHERN TRUST CORP - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 55 filers reported holding ENZO BIOCHEM INC in Q1 2023. The put-call ratio across all filers is 0.51 and the average weighting 0.3%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q3 2023$145,853
-24.2%
104,181
-0.4%
0.00%
Q2 2023$192,427
-22.7%
104,580
+2.1%
0.00%
Q1 2023$248,868
+67.8%
102,415
-1.3%
0.00%
Q4 2022$148,342
-36.1%
103,736
-0.3%
0.00%
Q3 2022$232,000
+0.9%
104,068
-6.3%
0.00%
Q2 2022$230,000
-28.8%
111,094
-0.4%
0.00%
Q1 2022$323,000
-12.0%
111,533
-2.6%
0.00%
Q4 2021$367,000
-3.2%
114,523
+7.0%
0.00%
Q3 2021$379,000
+8.3%
107,061
-3.1%
0.00%
Q2 2021$350,000
-77.7%
110,442
-75.8%
0.00%
Q1 2021$1,572,000
+21.9%
456,930
-10.7%
0.00%
Q4 2020$1,290,000
+13.1%
511,905
-5.3%
0.00%
Q3 2020$1,141,000
-7.2%
540,477
-1.5%
0.00%
Q2 2020$1,230,000
-10.2%
548,865
+1.5%
0.00%
Q1 2020$1,369,000
+1.4%
540,910
+5.4%
0.00%
Q4 2019$1,350,000
-30.0%
513,369
-4.2%
0.00%
Q3 2019$1,928,000
+1.7%
535,628
-4.7%
0.00%
Q2 2019$1,895,000
+25.1%
562,106
+1.3%
0.00%
Q1 2019$1,515,000
-1.4%
554,948
+0.4%
0.00%
Q4 2018$1,536,000
-34.9%
552,859
-3.4%
0.00%
-100.0%
Q3 2018$2,358,000
-16.8%
572,362
+4.8%
0.00%0.0%
Q2 2018$2,834,000
+1.5%
545,989
+7.1%
0.00%0.0%
Q1 2018$2,793,000
-29.1%
509,752
+5.5%
0.00%0.0%
Q4 2017$3,938,000
-25.3%
483,189
-4.1%
0.00%0.0%
Q3 2017$5,273,000
-5.8%
503,634
-0.6%
0.00%
-50.0%
Q2 2017$5,596,000
+43.5%
506,879
+8.8%
0.00%
+100.0%
Q1 2017$3,900,000
+22.7%
465,940
+1.8%
0.00%0.0%
Q4 2016$3,178,000
+34.2%
457,800
-1.6%
0.00%0.0%
Q3 2016$2,368,000
-14.6%
465,323
+0.1%
0.00%0.0%
Q2 2016$2,774,000
+557.3%
464,684
+401.0%
0.00%
Q1 2016$422,000
-4.1%
92,749
-5.2%
0.00%
Q4 2015$440,000
+48.1%
97,791
+4.4%
0.00%
Q3 2015$297,000
-73.6%
93,713
-74.8%
0.00%
Q2 2015$1,127,000
-6.9%
371,800
-9.3%
0.00%
Q1 2015$1,210,000
-34.9%
410,091
-2.0%
0.00%
-100.0%
Q4 2014$1,858,000
-10.3%
418,672
+4.0%
0.00%0.0%
Q3 2014$2,072,000
+189.4%
402,396
+195.1%
0.00%
Q2 2014$716,000
+65.4%
136,348
+30.8%
0.00%
Q1 2014$433,000
+54.1%
104,260
+8.2%
0.00%
Q4 2013$281,000
+12.0%
96,328
-3.1%
0.00%
Q3 2013$251,000
+7.3%
99,409
-11.7%
0.00%
Q2 2013$234,000112,6260.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q1 2023
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,392,642$6,939,00011.21%
VIEX Capital Advisors, LLC 1,435,130$4,162,0007.44%
HARBERT FUND ADVISORS, INC. 5,175,913$15,010,0006.29%
Potomac Capital Management, Inc. 496,805$1,441,0001.24%
AMH Equity Ltd 30,000$87,0000.09%
Corsair Capital Management 75,026$218,0000.05%
RBF Capital, LLC 250,359$730,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$74,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 539,954$1,566,0000.04%
Cutter & CO Brokerage, Inc. 25,777$75,0000.02%
View complete list of ENZO BIOCHEM INC shareholders